Konan, Japan

Tadashi Kurimoto

This inventor holds 5 USPTO granted patents. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1995-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadashi Kurimoto. Retrieved from https://idiyas.com/inventor/tadashi-kurimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Konan, JP (1995)
  • Konanmachi, JP (1998 - 2000)

Company Filing History:


Years Active: 1995-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Tadashi Kurimoto

Introduction

Tadashi Kurimoto is a notable inventor based in Konan-machi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzoylaminothiazole derivatives. With a total of 5 patents to his name, Kurimoto continues to push the boundaries of medicinal chemistry.

Latest Patents

Among his latest patents are the "Substituted benzoylaminothiazole derivatives and drugs containing the aminothiazole derivative" and "medicament containing the same." These inventions highlight his commitment to developing new therapeutic options that can improve patient outcomes.

Career Highlights

Kurimoto is currently employed at Zeria Pharmaceutical Co., Ltd., where he applies his expertise in drug development. His work has been instrumental in advancing the company's research initiatives and expanding its product offerings.

Collaborations

Throughout his career, Kurimoto has collaborated with esteemed colleagues such as Masaaki Nagasawa and Shigeru Ueki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Tadashi Kurimoto's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors on healthcare. His innovative patents and collaborative efforts continue to pave the way for advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…